Standout Papers

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC 2018 2026 2020 2023 2.6k
  1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC (2018)
    Mark A. Socinski, Robert M. Jotte et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 9 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Tumour vasculature at single-cell resolution
2024 StandoutNature
2 intermediate papers

Works of Ariel López-Chávez being referenced

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout

Author Peers

Author Last Decade Papers Cites
Ariel López-Chávez 2711 1853 805 41 3.6k
Hira Rizvi 2766 1639 657 64 3.4k
Kathryn C. Arbour 2456 1774 1278 50 3.7k
Kun He 1955 1223 805 53 3.1k
Joshua K. Sabari 2084 1319 957 82 2.9k
Albiruni R. Abdul Razak 1928 1075 1087 95 3.4k
Wei Zou 2996 1959 393 56 3.5k
Peter Langmuir 1811 1620 1289 55 4.6k
J. Thaddeus Beck 2572 1247 1231 112 3.6k
Asim Amin 2542 1050 874 73 3.3k
William J. Geese 2415 1375 472 42 2.9k

All Works

Loading papers...

Rankless by CCL
2026